Wille Finance

Online learning resources search engine

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. The company was founded in 2019 and is headquartered in Zurich, Switzerland.

Warehousing1 is building the number one warehousing and distribution network in Europe. Companies can utilize the innovative platform to find ideal warehousing solutions anywhere, manage them digitally and optimize processes by gaining real-time visibility and data transparency.

store.me is the Airbnb for storage space. It connects people providing or seeking storage space. The platform enables to rent underutilized cellars, garages or other empty rooms. On the other hand, people can find a suitable storage space or a garage in the desired area in Austria. Price, rental period and date are agreed directly between the lessor and the leaser. Apart from the integrated storage space management for lessors the platform also provides flexible insurance packages for the stored goods as well as transport and cleaning services.

Developer of a digital health platform intended to assist women, men, and couples throughout their fertility journeys. The company's platform helps patients to find the right fertility clinic and also accompanies the patients from the first consultation to the birth of their dream child, enabling patients to have the desire for children, artificial insemination, and social freezing during pregnancy.

Oculis is a clinical-stage biotechnology company dedicated to developing innovative topical treatments for ophthalmic diseases affecting both the anterior and posterior segments of the eye. Founded in 2003 and headquartered in Reykjavik, Iceland, Oculis utilizes a unique drug delivery platform that enhances drug absorption through a novel technique, enabling effective treatment of conditions such as diabetic macular edema, uveitis, chronic dry eye syndrome, glaucoma, and diabetic retinopathy with simple eye drops. This approach allows for non-invasive treatment of diseases at the back of the eye, traditionally requiring more complex methods, while also reducing the frequency of applications needed for anterior eye conditions. Oculis is committed to improving patient outcomes and enhancing the quality of life for individuals with vision-related health issues.

Visus Therapeutics is a clinical-stage company focused on developing innovative ophthalmic therapies aimed at enhancing vision for individuals globally. The company is known for its presbyopia-correcting eye drops, which are designed to provide temporary relief from the loss of near vision associated with presbyopia. Additionally, Visus Therapeutics is engaged in the development of various ophthalmic product candidates targeting conditions such as ocular surface disease, glaucoma, and age-related macular degeneration. Through its research and product offerings, the company seeks to address significant unmet needs in vision care.

T3 Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, founded in 2015. The company focuses on the research and development of bacteria-based therapies specifically designed for cancer treatment. Recognizing the ongoing need for innovative solutions in oncology, T3 Pharmaceuticals aims to enhance the lives of cancer patients by creating highly specific and efficient treatments using live bacteria. Through its work, the company seeks to address the limitations of conventional therapies and contribute to the advancement of novel cancer medicines.

Hillo designs, develops, and operates artificial intelligence platform to transform diabetic patient's lives. The company develops tools to anticipate blood glucose level. Hillo was founded in 2016 and is based in Palaiseau, France.

Raziel Health is focused on developing innovative treatments for obesity and fat disorders, particularly through its injectable drug RZL-012. This novel synthetic small molecule is designed to be injected directly into fat tissue, where it induces fat cell death, leading to a reduction in fat at the injection site. The company, founded in 2012 and based in Rehovot, Israel, aims to provide accessible and cost-effective healthcare solutions that enhance patient experience and promote timely clinical interventions. By integrating user-friendly technologies and leveraging data analytics, Raziel Health supports wellness and disease management, ensuring that individual patient goals are met effectively.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company based in Schlieren, Switzerland, founded in 2014. The company specializes in the discovery and development of novel human immunomodulatory proteins aimed at enhancing cancer treatment and addressing autoimmune diseases. By focusing on next-generation therapeutics, ImmunOs aims to create drugs that not only exhibit direct anti-tumor effects but also remodel the tumor microenvironment. Additionally, the company is developing antibodies designed to block the activation of specific HLA molecules associated with autoimmune conditions. Through its innovative approach, ImmunOs Therapeutics seeks to improve the lives of patients suffering from serious diseases.

BOX ID Systems GmbH, founded in 2018 and headquartered in Munich, Germany, specializes in developing Internet of Things (IoT) based positioning and identification systems for the industrial supply chain. The company offers innovative solutions such as BOX ID DoubleTrack and BOX ID TripleTrack, which provide real-time tracking of mobile assets and containers in logistics processes, both indoors and outdoors. Their end-to-end location and process mining solution allows for the efficient digital tracking of millions of logistics assets across various environments, including site-to-site and indoor applications. By utilizing specialized analytics software, sensor tracking devices, and user-management tools, BOX ID Systems enhances transparency and efficiency in logistics, enabling industrial and automotive production clients to optimize their supply chain processes and reduce costs. The company's commitment to delivering seamless location tracking and process automation supports clients in achieving greater operational effectiveness.

Hillo designs, develops, and operates artificial intelligence platform to transform diabetic patient's lives. The company develops tools to anticipate blood glucose level. Hillo was founded in 2016 and is based in Palaiseau, France.

Labiotech UG operates a biotechnology news Website. Its Website provides news in the areas of health, non-health, research, start-up, finance, and market access; and features news, such as reviews, interviews, tops, biotech of the week, and inside news. The company also provides advertising opportunities. It provides biotechnology news of various locations, including Austria, Belgium, France, Germany, Luxemburg, the Netherlands, Switzerland, Denmark, Finland, Iceland, Ireland, Sweden, Norway, the United Kingdom, Israel, Italy, Portugal, Spain, Turkey, Poland, Slovakia, and Czech Republic. Labiotech UG was founded in 2014 and is based in Berlin, Germany.

Nezasa AG operates a travel booking platform focused on individual travelers in Asia, providing a comprehensive solution for creating, personalizing, and booking travel packages. Founded in 2012 and based in Zurich, Switzerland, Nezasa enables customers to book various services, including hotels, transfers, and activities, catering to both economy and business class travelers. The platform is designed for flexibility, allowing users to adjust itineraries in real time to meet their preferences while maintaining consistency and managing the complexity of travel arrangements. Additionally, Nezasa offers tailored services for specific interests, such as golfing and short leisure trips for business travelers originating from Shanghai. Through its innovative software solutions, Nezasa aims to enhance the travel experience by facilitating seamless booking and providing opportunities for in-destination upselling.

Nezasa AG operates a travel booking platform focused on individual travelers in Asia, providing a comprehensive solution for creating, personalizing, and booking travel packages. Founded in 2012 and based in Zurich, Switzerland, Nezasa enables customers to book various services, including hotels, transfers, and activities, catering to both economy and business class travelers. The platform is designed for flexibility, allowing users to adjust itineraries in real time to meet their preferences while maintaining consistency and managing the complexity of travel arrangements. Additionally, Nezasa offers tailored services for specific interests, such as golfing and short leisure trips for business travelers originating from Shanghai. Through its innovative software solutions, Nezasa aims to enhance the travel experience by facilitating seamless booking and providing opportunities for in-destination upselling.